Novel 5 '-utrophin isoforms exhibit species-specific transcriptional profiles and provide additional candidates for therapeutic up-regulation in DMD

Documenti analoghi

• Analysis of the transcriptional control of utrophin promoters as a therapeutic strategy for Duchenne muscular dystrophy (DMD).
  di: Perkins, K, et al.
  Pubblicazione: (2000)
• Second-generation compound for the modulation of utrophin in the therapy of DMD
  di: Guiraud, S, et al.
  Pubblicazione: (2015)
• Identification of serum protein biomarkers for utrophin based DMD therapy.
  di: Guiraud, S, et al.
  Pubblicazione: (2017)
• Utrophin upregulation in DMD therapy: current status and new tools for the future
  di: Fairclough, R, et al.
  Pubblicazione: (2011)
• The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.
  di: Perkins, K, et al.
  Pubblicazione: (2001)